A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma
Hematological Oncology - United Kingdom
doi 10.1002/hon.21_2632
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley